Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS national Generic Pharmaceuticals Transition 2021_2

The NHS Commissioning Board (operating under the name of NHS England)

This public procurement record has 2 releases in its history.

Award

04 Jun 2021 at 11:32

Award Notice
Tender

19 Jan 2021 at 17:50

Tender Notice
Summary of the contracting process

The NHS Commissioning Board, operating under the name of NHS England, has initiated a procurement process titled "NHS National Generic Pharmaceuticals Transition 2021_2" within the pharmaceuticals industry. This ongoing tender, classified under CPV code 33600000, aims to establish a framework agreement lasting up to 39 months, including options to extend. The tender encompasses multiple lots with specific call-off periods for various pharmaceutical products, commencing on 15 June 2021 and concluding with different end dates extending until January 2023. Bids must be submitted electronically through the eTendering portal by 23 February 2021, at which point the bids will be opened at the designated address in Runcorn.

This procurement presents significant opportunities for businesses within the pharmaceutical sector, particularly those specialising in generic pharmaceuticals and healthcare services. Companies that are adept in delivering oral and non-parenteral products, as well as hospital housekeeping services, would be well-positioned to compete for this contract. Given the framework's extensive potential participant capacity and the considerable contract values across various lots, there is ample scope for both small and large businesses to engage and expand their market presence through successful bidding.

How relevant is this notice?

Notice Information

Notice Title

NHS national Generic Pharmaceuticals Transition 2021_2

Notice Description

Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: Allregions: 15/06/2021 to 28/02/2022 (8.5months)Transition CESW: 15/06/2021 to30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5months)NWLN: 15/06/2021 to 31/01/2022 (7.5months)Hospital Only Housekeeping Products:All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Lot Information

Lot 6 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLN/DCE/DSW Regions

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Plus options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

Lot 3 - CM/PHG/20/5631/00 Transition Products - NWLN Region

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2 Offer reference number: CM/PHG/20/5631 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months) OJEU Reference number: Potential periods of call-offs under the framework agreement: Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months) Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months) LSNE: 15/06/2021 to 31/01/2023 (19.5 months) NWLN: 15/06/2021 to 31/01/2022 (7.5 months) Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

Lot 4 - CM/PHG/20/5631/01 - Oral (plus non-parenteral) Products - All Regions

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Options to extend (at the Authority's sole discretion) for up to a further 8.5 months)

Lot 2 - CM/PHG/20/5631/00 Transition Products - LSNE Region

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2 Offer reference number: CM/PHG/20/5631 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months) OJEU Reference number: Potential periods of call-offs under the framework agreement: Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months) Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months) LSNE: 15/06/2021 to 31/01/2023 (19.5 months) NWLN: 15/06/2021 to 31/01/2022 (7.5 months) Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: options to extend (at the Authority's sole discretion) for up to a further 19.5 months)

Lot 1 - CM/PHG/20/5631/00 Transition Products - CESW Region

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Options to extend (at the Authority's sole discretion) for up to a further 12.5 months)

Lot 5 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLS/DNE/DNW Regions

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

Lot 1 - CM/PHG/20/5631/00 Transition Products - CESW Region

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Options to extend (at the Authority's sole discretion) for up to a further 12.5 months)

Lot 2 - CM/PHG/20/5631/00 Transition Products - LSNE Region

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: options to extend (at the Authority's sole discretion) for up to a further 19.5 months)

Lot 3 - CM/PHG/20/5631/00 Transition Products - NWLN Region

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

Lot 6 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLN/DCE/DSW Regions

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Hide Section - II.2.5) Award CriteriaII.2.5) Award Criteria. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Plus options to extend (at the Authority's sole discretion) for up to a further 7.5 months)Hide Section - II.2.12) eCatalogue requirementsII.2.12) eCatalogue requirements

Lot 4 - CM/PHG/20/5631/01 - Oral (plus non-parenteral) Products - All Regions

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Options to extend (at the Authority's sole discretion) for up to a further 8.5 months)

Lot 5 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLS/DNE/DNW Regions

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Hide Section - II.2.5) Award CriteriaII.2.5) Award Criteria. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-028bae
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/012546-2021
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

33690000 - Various medicinal products

Notice Value(s)

Tender Value
£115,932,694 £100M-£1B
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
4 Jun 20215 years ago
Submission Deadline
23 Feb 2021Expired
Future Notice Date
Not specified
Award Date
7 May 20215 years ago
Contract Period
15 Jun 2021 - 31 Jan 2022 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Active, Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The NHS Commissioning Board (operating under the name of NHS England)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
Not specified
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
17
Supplier Names

Accord-UK Ltd

Amarox Limited

Aspire Pharma Limited

Bristol Laboratories Limited

Brown and Burk UK Ltd

Cipla (EU) Ltd

Day Lewis Medical Ltd

Dr.Reddy's Laboratories (UK) Limited

Laboratorio Reig Jofre SA

Lexon UK Ltd

Milpharm Ltd/aurobinbdo

Morningside Pharmaeuticals

Neon Healthcare Ltd

Ranbaxy UK

Selective Supplies Ltd.

Thornton and Ross Ltd

Waverley Pharma Europe Limited

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...